Serum HBV RNA May Predict Response To PEG-IFN Treatment In Patients With HBeAg-Positive Chronic HBV, Researchers Say
April 23, 2020
Infectious Disease Advisor (4/22, Schad) reports, “Hepatitis B virus (HBV) RNA in serum declines profoundly during treatment with pegylated interferon (PEG-IFN); therefore, early on-treatment HBV RNA levels may be used to predict nonresponse,” investigato...